CLARI.PA Clariane SE
- Market cap
- EUR 1.24B
- P/E
- 116.1x
- P/B
- 0.34x
- ROE
- -5.3%
- Dividend yield
- 5.62%
- Fundamental score
- 0.0/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is CLARI.PA undervalued?
Graham numberCLARI.PA trades 33.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Clariane SE fundamental analysis
0 of 11 checks passedROE 0/2
Unidentified ROE
ROA 0/2
Unidentified ROA
PBV 0/2
Unidentified ROA
DER 0/2
Unidentified DER
Revenue Growth 0/2
Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.
Net Profit Growth 0/2
Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.
Assets Growth 0/2
Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.
Graham Number 0/1
Unidentified Graham Number
Dividend Growth 0/2
The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.
Dividend 0/2
No dividends from the company in the past three years raises doubts about its profitability for shareholders.
Buffet Intrinsic Value 0/1
Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Clariane SE stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Clariane SE
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. …
Full company profileClariane SE financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Clariane SE annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.98B | 3.13B | 3.34B | 3.61B | 3.77B | 4.14B | 4.44B | 5.00B | 5.28B | 5.31B | 10.8B |
| Gross Profit | 2.74B | 2.88B | 3.07B | 3.34B | 3.48B | 3.83B | 4.09B | 1.57B | 4.84B | 432M | 866M |
| Operating Income | 241M | 283M | 299M | 359M | 266M | 342M | 273M | 163M | 262M | 297M | 635M |
| EBITDA | 367M | 437M | 441M | 850M | 829M | 944M | 907M | 957M | 1.01B | 1.01B | 2.02B |
| Net Income | 131M | 163M | 123M | 115M | 39.4M | 91.1M | 22.1M | -105M | -55.1M | 1.60M | -190M |
| EPS | 1.45 | 1.72 | 1.28 | 1.19 | 0.37 | 0.75 | 0.18 | -0.72 | -0.24 | 0.00 | -0.53 |
| Balance Sheet | |||||||||||
| Total Assets | 6.49B | 7.11B | 7.62B | 10.9B | 13.2B | 14.3B | 14.6B | 15.2B | 14.3B | 13.8B | 14.4B |
| Total Liabilities | 4.46B | 4.64B | 5.06B | 8.37B | 9.87B | 10.5B | 10.7B | 11.2B | 10.2B | 9.89B | 10.4B |
| Shareholders' Equity | 2.02B | 2.46B | 2.56B | 2.56B | 3.16B | 3.49B | 3.54B | 3.58B | 3.69B | 3.61B | 3.62B |
| Cash & Short-term Investments | 310M | 512M | 550M | 345M | 1.16B | 1.22B | 734M | 678M | 518M | 822M | 1.42B |
| Total Debt | 2.63B | 2.85B | 3.27B | 6.51B | 7.80B | 8.23B | 8.27B | 8.55B | 7.98B | 7.81B | 8.35B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 307M | 385M | 377M | 766M | 795M | 840M | 862M | 653M | 900M | 796M | 1.09B |
| Capital Expenditure | 160M | 189M | 265M | 326M | 520M | 529M | 565M | 484M | 308M | 219M | 448M |
| Free Cash Flow | 148M | 197M | 113M | 439M | 275M | 311M | 116M | 320M | 600M | 578M | 644M |
| Ratios | |||||||||||
| ROE | 6.5% | 6.6% | 4.8% | 4.5% | 1.2% | 2.6% | 0.6% | -2.9% | -1.5% | 0.0% | -5.3% |
| ROA | 2.0% | 2.3% | 1.6% | 1.0% | 0.3% | 0.6% | 0.2% | -0.7% | -0.4% | 0.0% | -1.3% |
| Net Profit Margin | 4.4% | 5.2% | 3.7% | 3.2% | 1.0% | 2.2% | 0.5% | -2.1% | -1.0% | 0.0% | -1.8% |
| Debt to Equity | 1.30x | 1.16x | 1.28x | 2.54x | 2.47x | 2.36x | 2.34x | 2.39x | 2.16x | 2.16x | 2.31x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Clariane SE dividends
- Dividend yield
- 5.62%
- Forward dividend
- -
- Payout ratio
- 4,372.3%
- Ex-dividend date
- Jun 21, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 70.0M | 0.20 | 4,372.3% |
| 2024 | EUR 50.8M | 0.22 | - |
| 2023 | EUR 65.7M | 0.45 | - |
| 2022 | EUR 57.8M | 0.48 | 262.1% |
| 2021 | EUR 36.4M | 0.30 | 40.0% |
| 2020 | EUR 10.2M | 0.10 | 26.0% |
| 2019 | 24.7M | 0.26 | 21.5% |
| 2018 | 24.9M | 0.26 | 20.2% |
| 2017 | 30.6M | 0.32 | 18.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 6:1 on May 31, 2001.
Who owns Clariane SE
- Insiders 35.81%
- Institutions 36.26%
- Public & others 27.94%
- Shares outstanding 357M
- Free float 136M
Clariane SE company profile
- Company name
- Clariane SE
- Ticker
- CLARI.PA
- ISIN
- FR0010386334
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 70,685
- Fiscal year end
- December
- Address
- 21-25, rue Balzac, Paris, France, 75008
- Phone
- 33 1 55 37 52 00
- Website
- clariane.com
About Clariane SE
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living solutions, such as shared houses, assisted living, and domiciliary care, as well as outpatient consultations and diagnostics, and social care services. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.
Clariane SE management
10- Madam Sophie BoissardCEO & Director · born 1970
- Mr. Grégory LovichiGroup Chief Financial Officer · born 1980
- Mr. Christian GhariebCEO of Korian Germany & Member of the Group's Management Board
- Mr. Aymeric MathiasPresident of Clariane France & Member of the Group's Management Board
- Stephane BisseuilHead of Investor Relations
- Mr. Nicolas PecourtGroup Chief Communications Officer
- Ms. Nadege PlouGroup Chief Human Resources Officer · born 1976
- Mr. Rémi BoyerDeputy CEO & Chair of the Sup. Board of Korian Germany and Chair of the BOD of Korian Belgium · born 1967
- Mr. Charles-Antoine PinelGroup Chief Revenue & Development Officer · born 1972
- Mr. Frédéric DurousseauChief Executive Officer of Clariane Real Estate · born 1973